Correlation Between La Z and Moderna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both La Z and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining La Z and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between La-Z-Boy and Moderna, you can compare the effects of market volatilities on La Z and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in La Z with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of La Z and Moderna.

Diversification Opportunities for La Z and Moderna

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between La Z and Moderna is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding La-Z-Boy and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and La Z is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on La-Z-Boy are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of La Z i.e., La Z and Moderna go up and down completely randomly.

Pair Corralation between La Z and Moderna

Considering the 90-day investment horizon La-Z-Boy is expected to generate 0.72 times more return on investment than Moderna. However, La-Z-Boy is 1.39 times less risky than Moderna. It trades about -0.26 of its potential returns per unit of risk. Moderna is currently generating about -0.2 per unit of risk. If you would invest  2,619  in La-Z-Boy on July 3, 2022 and sell it today you would lose (362.00)  from holding La-Z-Boy or give up 13.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

La-Z-Boy  vs.  Moderna

 Performance (%) 
       Timeline  
La-Z-Boy 
La Z Performance
0 of 100
Over the last 90 days La-Z-Boy has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

La Z Price Channel

Moderna 
Moderna Performance
0 of 100
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in November 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Moderna Price Channel

La Z and Moderna Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with La Z and Moderna

The main advantage of trading using opposite La Z and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if La Z position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.
La Z vs. Amazon Inc
The idea behind La-Z-Boy and Moderna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Moderna vs. Fair Isaac And
Moderna vs. Ptc Inc
Moderna vs. Atlassian Cls A
Moderna vs. Hubspot
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go